New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Veracyte, Inc.
VCYT
Shape
US Flag

NASDAQ

EPS improving

EPS improving

3B

Biotechnology

Next Earning date - 06 Nov 2024

3B

Biotechnology

Next Earning date - 06 Nov 2024

33.03USD
Shape0.25 ( 0.76%)
favorite-chart

Relative Strenght

21
favorite-chart

Volume Buzz

-49%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

7%

Quote Panel

Shape
Updated October 27, 2024
1W -0.27 % 1M -2.97 % 3M 43.42 % 1Y 63.35 %

Key Metrics

Shape
  • Market Cap

    2.54B


  • Shares Outstanding

    76.81M


  • Share in Float

    75.65M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    33.03


  • Average Volume

    883482


  • Beta

    1.665


  • Range

    18.61-35.51


  • Industry

    Biotechnology


  • Website

    https://www.veracyte.com


  • Sector

    Healthcare


Fundamentals

Shape

157.29x

P/E Ratio

6.35x

P/S Ratio

2.23x

P/B Ratio

0.0

Debt/Equity

-13.5%

Net Margin

$-0.7

EPS

How VCYT compares to sector?

P/E Ratio

Relative Strength

Shape

VCYT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

UBS

initialise

Previous: Not converted

2024-10-15

Now: Buy

Guggenheim

initialise

Previous: Not converted

2024-10-10

Now: Buy

Scotiabank

initialise

Previous: Not converted

2023-01-05

Now: Sector Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.12
vs -0.13

Q4.22

arrow
arrow

N/A

-0.05
vs -0.15

Q1.23

arrow
arrow

N/A

-0.11
vs -0.20

Q2.23

arrow
arrow

N/A

-0.12
vs -0.13

Q3.23

arrow
arrow

N/A

-0.03
vs -0.12

Q4.23

arrow
arrow

N/A

-0.04
vs -0.05

Q1.24

arrow
arrow

N/A

-0.02
vs -0.11

Q2.24

arrow
arrow

+350%

0.3
vs -0.12

Q3.24

arrow
arrow

+208%

0.03
vs -0.03

Q4.24

arrow
arrow

+275%

0.07
vs -0.04

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+25%

75.6M  vs 60.4M

Q4.22

arrow
arrow

+19%

80.3M  vs 67.3M

Q1.23

arrow
arrow

+22%

82.4M  vs 67.8M

Q2.23

arrow
arrow

+24%

90.3M  vs 72.9M

Q3.23

arrow
arrow

+19%

90.1M  vs 75.6M

Q4.23

arrow
arrow

+22%

98.2M  vs 80.3M

Q1.24

arrow
arrow

+18%

96.8M  vs 82.4M

Q2.24

arrow
arrow

+27%

114.4M  vs 90.3M

Q3.24

arrow
arrow

+22%

109.9M  vs 90.1M

Q4.24

arrow
arrow

+17%

115.1M  vs 98.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-1%

-0.01
vs -0.01

Q4.22

arrow
arrow

0%

-0.00
vs -0.01

Q1.23

arrow
arrow

-1%

-0.01
vs -0.00

Q2.23

arrow
arrow

-1%

-0.01
vs -0.01

Q3.23

arrow
arrow

-3%

-0.03
vs -0.01

Q4.23

arrow
arrow

-3%

-0.03
vs -0.03

Q1.24

arrow
arrow

0%

-0.00
vs -0.03

Q2.24

arrow
arrow

+1%

0.01
vs -0.00

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

206

206
vs 195

6%

Q4.22

arrow
arrow

223

223
vs 206

8%

Q1.23

arrow
arrow

231

231
vs 223

4%

Q2.23

arrow
arrow

231

231
vs 231

NA

Q3.23

arrow
arrow

237

237
vs 231

3%

Q4.23

arrow
arrow

252

252
vs 237

6%

Q1.24

arrow
arrow

244

244
vs 252

-3%

Q2.24

arrow
arrow

239

239
vs 244

-2%

Earnings Growth

Latest News